Literature DB >> 4474966

The clinical significance of highly purified pig-insulin preparations.

T Deckert, O O Andersen, J E Poulsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4474966     DOI： 10.1007/bf01219531

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  19 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Recrystallized insulin for diabetic patients with insulin allergy.

Authors:  J E JORPES
Journal:  Arch Intern Med (Chic)       Date:  1949-04

3.  An insulin hazard?

Authors: 
Journal:  Lancet       Date:  1966-10-22       Impact factor: 79.321

4.  Insulin antibodies in aetiology of labile diabetes.

Authors:  K Dixon; P D Exon; H R Hughes
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321

5.  Variations in the incidence of lipodystrophy using different insulins.

Authors:  D Watson; R Vines
Journal:  Med J Aust       Date:  1973-02-03       Impact factor: 7.738

6.  [Experiences with monocomponent insulin treatment].

Authors:  W Korp; R E Levett
Journal:  Wien Klin Wochenschr       Date:  1973-05-04       Impact factor: 1.704

7.  Clinical aspects of insulin--antigenicity.

Authors:  J Schlichtkrull; J Brange; A H Christiansen; O Hallund; L G Heding; K H Jorgensen
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

8.  Antibody studies in patients on mixed bovine-porcine insulins.

Authors:  J G Devlin; M Duggan
Journal:  Diabetologia       Date:  1969-06       Impact factor: 10.122

9.  Studies of small vessels in patients with diabetes. A clinical, histological and immunohistochemical study of diabetic and non-diabetic subjects with special reference to the occurrence of various plasma proteins in the dermal vessel walls.

Authors:  O Larsson
Journal:  Acta Med Scand Suppl       Date:  1967

10.  [Insulin-binding capacity of the serum in diabetic patients with increased insulin need].

Authors:  J Kühnau
Journal:  Verh Dtsch Ges Inn Med       Date:  1968
View more
  11 in total

1.  Very pure porcine insulin in clinical practice.

Authors:  A D Wright; C H Walsh; M G Fitzgerald; J M Malins
Journal:  Br Med J       Date:  1979-01-06

2.  Twenty-four-hour metabolic profiles in diabetic children receiving insulin injections once or twice daily.

Authors:  G A Werther; P A Jenkins; R C Turner; J D Baum
Journal:  Br Med J       Date:  1980-08-09

3.  Highly purified insulins.

Authors:  K G Alberti; M Nattrass
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

4.  Regulation of brittle diabetics by a pre-planned insulin infusion programme.

Authors:  T Deckert; B Lorup
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

5.  Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.

Authors:  A Czyzyk; H Rogala; J Lawecki
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

6.  Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo).

Authors:  K Kølendorf; P Aaby; S Westergaard; T Deckert
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

7.  Prognosis of diabetics with diabetes onset before the age of thirty-one. II. Factors influencing the prognosis.

Authors:  T Deckert; J E Poulsen; M Larsen
Journal:  Diabetologia       Date:  1978-06       Impact factor: 10.122

Review 8.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

9.  The immunogenic properties of a highly purified insulin preparation.

Authors:  N T Manning; M I Drury
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

10.  One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus.

Authors:  Marc Evans; Angharad R Morgan; Stephen C Bain
Journal:  Diabetes Ther       Date:  2021-04-26       Impact factor: 2.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.